Table 2.
Programme losses (mortality and lost to follow-up (LTFU) in all adolescents and perinatally infected adolescents (9-19 years) compared with that of young adults (20-28 years)
| Mortality | LTFU | |||||
|---|---|---|---|---|---|---|
| Age group | Rates (per 100 PYS) | AHR* | p-value | Rates (per 100 PYS) | AHR* | p-value |
| All adolescents | 1.2 (0.3-4.8) | 0.56 (0.13-2.32) | 0.42 | 7.2 (4.1-12.6) | 0.74 (0.41-1.34) | 0.33 |
| Perinatally infected adolescents | 0.8 (0.1-5.5) | 0.39 (0.05-2.86) | 0.35 | 3.9 (1.6-9.4) | 0.39 (0.16-0.96) | 0.04 |
| Young adults (ref) | 3.1 (2.4-3.9) | 1.00 | - | 10.2 (9.0-11.7) | 1.00 | - |
PYS person-years; UHR unadjusted hazard ratio; AHR adjusted hazard ratio
*adjusted for gender, baseline CD4, baseline viral load